Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.
The impact of chemotherapy on longitudinal vascular changes taking place during the growth of an animal tumor, R3230 AC adenocarcinoma, was investigated. Two contrast agents of different molecular weights, gadolinium-diethylene-triamine-pentaacetic acid (Gd-DTPA; < 1 kD) and gadomer-17 (35 kD), were used in the dynamic imaging studies. Enhancement kinetics were analyzed by a pharmacokinetic model to derive parameters related to vascular volume and permeability on a pixel-by-pixel basis. Responders and non-responders were separated according to tumor size 10 days after the therapy. Changes in the vascular volume measured by gadomer-17 at 4 days after therapy revealed a clear distinction between the controls and the responders/non-responders. Mean vascular volume decreased by 42% in responders but was not significantly changed in the controls. The one non-responder had increased vascular volume after chemotherapy. Enhancement kinetics of gadomer-17 detected the changes earlier and with greater sensitivity than Gd-DTPA. In the control group, vascular permeability determined by gadomer-17 correlated with the longitudinal growth rates of tumors, suggesting that vascular permeability assessed by gadomer-17 could potentially serve as an indicator of aggressive tumor growth.
Su
M Y
MY
Health Sciences Research Imaging Center, College of Medicine, University of California, Irvine 92697-5020, USA.
Wang
Z
Z
Nalcioglu
O
O
D000230:Adenocarcinoma / Q000098:blood supply* / Q000188:drug therapy*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D002199:Capillary Permeability; D003287:Contrast Media; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use; D019786:Gadolinium DTPA; D008279:Magnetic Resonance Imaging / Q000379:methods*; D016685:Mitomycin / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000098:blood supply* / Q000188:drug therapy*; D051381:Rats; D011916:Rats, Inbred F344; D012680:Sensitivity and Specificity; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D003287:Contrast Media; D005419:Flavonoids; D016685:Mitomycin; C049328:flavone acetic acid; D019786:Gadolinium DTPA